BME100 s2014:W Group6 L2
|  BME 100 Fall 2013 | Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help | |||||
|   | ||||||
| Group 6LAB 2 WRITE-UPDescriptive StatisticsExperiment 1  Dosage in Humans 3.834 8.932 61.622 657.941 Average Inflammotin (pg/ml) 3.834 8.932 61.622 657.941 Standard Deviation 1.52301018 1.59393155 30.1106939 212.942976 Standard Error 0.48161811 0.50404541 9.52183745 67.3384817 
 Dosage in rats 0mg 10mg Average Inflammotin (pg/ml) 10.516 11.112 Standard Deviation 2.22555162 7.40288592 Standard Error 0.99529694 3.31067123 
 
 ResultsExperiment 1  t-test value 8.59631E-07 9.94377E-06 1.39436E-08 3.01859E-05 1.57101E-08 6.4824E-08 Corrected p-value 0.0125 0.0125 0.0125 0.0125 0.0125 0.0125 Significant? YES YES YES YES YES YES 
 Experiment 2  Inferential data for the rats: P- Value from t-test = 0.8674035 
 AnalysisExperiment 1  
 
 Summary/DiscussionOur data shows that raising the dosage of LPS by 5mg increments in humans results in significant changes in inflammotin, meaning that patients requiring stronger medication may be sufficiently helped through 5mg dosage increases; however, this is not the case in the rats. Even more surprising, is that no change was found in rats for an even larger difference in dosage – 10mg. Perhaps this indicates that rats have some natural resistance to the drug. | ||||||